טוען...
Current State of Commercial Point-of-Care Nucleic Acid Tests for Infectious Diseases
The COVID-19 pandemic has put the spotlight on the urgent need for integrated nucleic acid tests (NATs) for infectious diseases, especially those that can be used near patient (“point-of-care”, POC), with rapid results and low cost, but without sacrificing sensitivity or specificity of gold standard...
שמור ב:
| הוצא לאור ב: | Analyst |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139840/ https://ncbi.nlm.nih.gov/pubmed/33899053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0an01988g |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|